-
July 12: The Week in Cancer News
A combination of three targeted therapies can lengthen survival for some patients with metastatic colorectal cancer, and patients receiving stem cell transplants can benefit from shingles vaccines.
by Kate Yandell
-
June 28: The Week in Cancer News
A study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.
by Kate Yandell
-
June 21: The Week in Cancer News
A study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.
by Kate Yandell
-
June 14: The Week in Cancer News
A physician writes about the long-term effects of her treatment for Hodgkin lymphoma in the 1960s, and the U.S. Food and Drug Administration approves an immunotherapy drug as an initial treatment for metastatic head and neck cancer.
by Kate Yandell
-
June 7: The Week in Cancer News
A study finds that a targeted therapy approved to treat advanced breast cancer lengthens survival, and data indicate that Medicaid expansion has helped ease racial disparities in access to cancer care.
by Kate Yandell
-
May 31: The Week in Cancer News
A study finds that oral cancer medication costs for patients covered by Medicare Part D have increased, and the U.S. Food and Drug Administration approves a new targeted therapy for advanced breast cancer.
by Kate Yandell
-
May 24: The Week in Cancer News
Unequal access to care appears to be responsible for the elevated mortality rate from prostate cancer in black men, and women with a history of cancer who identify as lesbian or bisexual have reduced access to care.
by Kate Yandell
-
May 17: The Week in Cancer News
A study indicates that the Affordable Care Act decreased the proportion of people with a history of cancer who are uninsured, and access to appropriate targeted therapies may be lacking for some patients.
by Kate Yandell
-
May 10: The Week in Cancer News
The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.
by Kate Yandell and Bradley Jones
-
The Week in Cancer News: May 3
Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.
by Bradley Jones
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore